Fundraising Fox

XCR Diagnostics

Salt Lake City, US · Utah corporation

XCR Diagnostics develops portable molecular diagnostic systems for rapid nucleic acid testing at the point of care. The Pyramid system delivers lab-quality results in approximately 7 minutes for infectious disease detection in hospitals, clinics, emergency rooms, and resource-limited settings.

Founders & leadership

MP
Mark PowelsonExecutive

Reported raises · per SEC filings

Form D private placements

$4.3M disclosed across 2 rounds · 2016–2019

$1.8MraisedOct 2019 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark PowelsonExecutive Officer, Director
Offering amount
$2M
Amount sold
$1.8M
Proceeds to insiders
$50K
First sale
Sep 2019
Incorporated
Corporation, Utah
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.5MraisedDec 2016 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark PowelsonExecutive Officer, Director
  • Brian CaplinExecutive Officer, Promoter
  • Ann Marie BuoscioExecutive Officer
  • Linda MerrillDirector
  • Mark BagnallDirector
Offering amount
$2.5M
Amount sold
$2.5M
Minimum investment
$20K
Sales commissions
$250K
Proceeds to insiders
$500K
Placement agents
ACAP Financial Inc
First sale
Mar 2016
Incorporated
Corporation, Utah, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

What does XCR Diagnostics do?
XCR Diagnostics develops portable molecular diagnostic systems for rapid nucleic acid testing at the point of care. The Pyramid system delivers lab-quality results in approximately 7 minutes for infectious disease detection in hospitals, clinics, emergency rooms, and resource-limited settings.
How much funding has XCR Diagnostics raised?
XCR Diagnostics has disclosed $4.3M raised across 2 rounds.
Where is XCR Diagnostics headquartered?
XCR Diagnostics is headquartered in Salt Lake City, US.